“1 + 1 = 3”: The Added Value of Combining Immunohistochemistry and Dual-Probe Chromogen In Situ Hybridization to Improve HER2 Status Evaluation

Laboratory Investigation 2026

View at publisher
Authors: Valentina Angerilli, Alessandro Gambella, Simona Pigozzi, Alessandro Vanoli, Paola Parente, Alessandro Caputo, Federica Grillo, Matteo Fassan, Luca Mastracci
DOI: 10.1016/j.labinv.2026.106125
Cited by: 1
References: 10

Fields of Study & Subjects

HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research Advanced Biosensing Techniques and Applications

Publication details

Journal / source
Laboratory Investigation
Publisher
Elsevier BV
Volume
106
Issue
6
Pages
106125–106125
Publication date
5 May 2026
Language
EN